These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman JR, Wang JC. J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [Abstract] [Full Text] [Related]
4. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Miyazaki M, Zuk PA, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Wang JC. Spine (Phila Pa 1976); 2008 Apr 15; 33(8):863-9. PubMed ID: 18404105 [Abstract] [Full Text] [Related]
7. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Cheng SL, Lou J, Wright NM, Lai CF, Avioli LV, Riew KD. Calcif Tissue Int; 2001 Feb 15; 68(2):87-94. PubMed ID: 11310352 [Abstract] [Full Text] [Related]
8. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study]. Ma XS, Jiang JY, Lü FZ, Ma X, Li XK, Huang HY. Zhonghua Yi Xue Za Zhi; 2006 Dec 19; 86(47):3340-4. PubMed ID: 17313830 [Abstract] [Full Text] [Related]
11. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C. J Bone Miner Res; 2004 Dec 19; 19(12):2021-32. PubMed ID: 15537446 [Abstract] [Full Text] [Related]
12. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Akamaru T, Suh D, Boden SD, Kim HS, Minamide A, Louis-Ugbo J. Spine (Phila Pa 1976); 2003 Mar 01; 28(5):429-34. PubMed ID: 12616152 [Abstract] [Full Text] [Related]
14. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Patel VV, Zhao L, Wong P, Pradhan BB, Bae HW, Kanim L, Delamarter RB. Spine J; 2006 Mar 01; 6(4):397-403; discussion 404. PubMed ID: 16825045 [Abstract] [Full Text] [Related]
15. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Sugiyama O, An DS, Kung SP, Feeley BT, Gamradt S, Liu NQ, Chen IS, Lieberman JR. Mol Ther; 2005 Mar 01; 11(3):390-8. PubMed ID: 15727935 [Abstract] [Full Text] [Related]
17. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Park J, Ries J, Gelse K, Kloss F, von der Mark K, Wiltfang J, Neukam FW, Schneider H. Gene Ther; 2003 Jul 01; 10(13):1089-98. PubMed ID: 12808439 [Abstract] [Full Text] [Related]
19. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene. Tsuda H, Wada T, Yamashita T, Hamada H. J Gene Med; 2005 Oct 01; 7(10):1322-34. PubMed ID: 15926193 [Abstract] [Full Text] [Related]
20. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA. Gene Ther; 2003 Sep 01; 10(20):1735-43. PubMed ID: 12939640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]